U
CaliPharms, Inc. KGET
$0.00 $0.000.00%
Recommendation
--
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
--

09/30/2014 06/30/2014 09/30/2013
Total Cash And Short-Term Investments -82.85% 469.89% --
Total Receivables -- -- --
Inventory -- -- --
Prepaid Expenses -- 0.00% --
Finance Division Loans and Leases Current -- -- --
Total Finance Division Other Current Assets -- -- --
Other Current Assets -- -- --
Total Current Assets -85.82% 108.78% --

Total Current Assets -85.82% 108.78% --
Net Property, Plant & Equipment -- -- --
Long-term Investments -- -- --
Goodwill -- -- --
Total Other Intangibles -- -- --
Finance Div Loans & Leases LT -- -- --
Total Finance Div Other LT Assets -- -- --
Total Other Assets -- -- --
Total Assets -85.82% 108.78% --

Total Accounts Payable -36.84% 15.23% --
Total Accrued Expenses 1,063.94% 9.47% --
Short-term Debt -64.93% 14.96% --
Current Portion of Long-Term Debt/Capital Leases -- -- --
Finance Division Debt Current -- -- --
Total Finance Division Other Current Liabilities 1,286.32% 129.23% --
Total Other Current Liabilities 1,286.32% 129.23% --
Total Current Liabilities 125.28% 22.56% --

Total Current Liabilities 125.28% 22.56% --
Long-Term Debt -- -- --
Short-term Debt -64.93% 14.96% --
Capital Leases -- -- --
Finance Division Debt Non Current -- -- --
Total Finance Division Other Non Current Liabilities -- -- --
Total Other Liabilities -- 159.21% --
Total Liabilities 83.10% 35.98% --

Common Stock & APIC 0.33% 0.41% --
Retained Earnings -14.06% -4.61% --
Treasury Stock & Other -- -- --
Total Common Equity -87.47% -34.76% --

Preferred Stock Redeemable -- -- --
Preferred Stock Non Redeemable -- -- --
Preferred Stock Convertible -- -- --
Preferred Stock, Others -- -- --
Total Preferred Equity -- -- --

Total Common Equity -87.47% -34.76% --
Total Preferred Equity -- -- --
Total Minority Interest -- -- --
Total Equity -87.47% -34.76% --

Weiss Ratings